Blood CD33(+)HLA-DR(−) myeloid-derived suppressor cells are increased with age and a history of cancer
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Myeloid-derived suppressor cells are increased with age and elevated in donors with a history of cancer; an age-related effect has never been shown in humans. As we age, the composition of our peripheral leukocytes changes dramatically. Many of these alterations contribute to the general immune dysfunction that burdens the elderly, which in turn, contributes to increased susceptibility to disease. MDSCs represent a heterogeneous population of immunosuppressive leukocytes that are elevated in the peripheral blood of cancer patients. Given the relation between cancer incidence and age, this study examined the frequency of peripheral blood CD33(+)HLA-DR(−) MDSCs across three cohorts: healthy adults (19–59 years old), community-dwelling seniors (61–76 years old), and frail elderly (67–99 years old). This analysis is the first to demonstrate that MDSCs and specifically the CD11b(+)CD15(+) MDSC subset are increased with age. Proinflammatory cytokines that are required for the differentiation of MDSCs (e.g., TNF-α, IL-6, and IL-1β) were similarly found to be increased in the serum of the frail elderly. Furthermore, the proportion of MDSCs and the CD11b(+)CD15(+) subset were found to be elevated significantly in elderly donors with a history of cancer. This age-related elevation in the frequency of MDSCs may contribute to the increased cancer incidence that occurs with age. Further investigation into the functional consequences of elevated MDSCs will provide valuable insight into the progression of age-related pathologies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“IL-6 is elevated with age and coincides with increases in both circulating immunosuppressive myeloid cells and cancer incidence26.”
From Stromal senescence establishes an immunosuppressive microenvironment that drives tumorigenesis (2016) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Myeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753 · cited 1×
“sive, myeloid lineage cells in the peripheral blood [4].”
BackgroundDiaz-Montero, C. M., Salem, M. L., Nishimura, M. I., Garrett-Mayer, E., Cole, D. J., & Montero, A. J. (2009) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-008-0523-4 · Cited by 1,215 · cited 1×
“been found to be associated with clinical scores, such as tumor stage, burden, and metastasis [10, 15].”
BackgroundInflammatory markers in population studies of aging
Singh, T., & Newman, A. B. (2011) · Ageing Research Reviews · doi:10.1016/j.arr.2010.11.002 · Cited by 863 · cited 1×
“[19]).”
Ko, J. S., Zea, A. H., Rini, B. I., Ireland, J. L., Elson, P., Cohen, P., Golshayan, A., Rayman, P. A., Wood, L., Garcia, J., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1332 · Cited by 862 · cited 8×
“MDSCs (CD33 HLA-DR ) and the CD11b CD15 MDSC subset were found to be increased significantly in seniors (0.29 0.03 and 0.17 0.03, respectively) and the frail elderly (0.40 0.03 and 0.29 0.02, respectively) as compared with healthy adults (0.22 0.03 and 0.11 0.03, respectively; Fig.”
BackgroundInfluentialLechner, M. G., Liebertz, D. J., & Epstein, A. L. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000901 · Cited by 582 · cited 2×
“Furthermore, serum IL-6 has been shown to be correlated with MDSC frequency in patients with gastrointestinal cancer [20], and as mentioned above, proinflammatory cytokines are able to induce the differentiation of MDSCs in vitro [5, 8, 21].”
BackgroundRockwood, K., Song, X., & Mitnitski, A. (2011) · Canadian Medical Association Journal · doi:10.1503/cmaj.101271 · Cited by 573
Hearps, A. C., Martin, G. E., Angelovich, T. A., Cheng, W., Maisa, A., Landay, A. L., Jaworowski, A., & Crowe, S. M. (2012) · Aging Cell · doi:10.1111/j.1474-9726.2012.00851.x · Cited by 547
Obermajer, N., Muthuswamy, R., Lesnock, J., Edwards, R. P., & Kalinski, P. (2011) · Blood · doi:10.1182/blood-2011-07-365825 · Cited by 497
Inflammaging: disturbed interplay between autophagy and inflammasomes
Salminen, A., Kaarniranta, K., & Kauppinen, A. (2012) · Aging · doi:10.18632/aging.100444 · Cited by 453
Myeloid derived suppressor cells in human diseases
Greten, T. F., Manns, M. P., & Korangy, F. (2011) · International Immunopharmacology · doi:10.1016/j.intimp.2011.01.003 · Cited by 398 · cited 1×
“categories [6, 7].”
Liu, C.-Y., Wang, Y.-M., Wang, C.-L., Feng, P.-H., Ko, H.-W., Liu, Y.-H., Wu, Y.-C., Chu, Y., Chung, F.-T., Kuo, C.-H., et al. (2010) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-009-0634-0 · Cited by 313 · cited 1×
“quency does so in relation to cancers, such as renal and lung carcinoma, of which CD33 HLA-DR CD11b [9–12] and CD33 HLA-DR [13, 14] populations are found to be significantly increased.”
BackgroundJing, Y., Shaheen, E., Drake, R. R., Chen, N., Gravenstein, S., & Deng, Y. (2009) · Human Immunology · doi:10.1016/j.humimm.2009.07.005 · Cited by 284
Reversal of Myeloid Cell–Mediated Immunosuppression in Patients with Metastatic Renal Cell Carcinoma
Kusmartsev, S., Su, Z., Heiser, A., Dannull, J., Eruslanov, E., Kübler, H., Yancey, D., Dahm, P., & Vieweg, J. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0165 · Cited by 284 · cited 1×
“quency does so in relation to cancers, such as renal and lung carcinoma, of which CD33 HLA-DR CD11b [9–12] and CD33 HLA-DR [13, 14] populations are found to be significantly increased.”
BackgroundRosenkranz, D., Weyer, S., Tolosa, E., Gaenslen, A., Berg, D., Leyhe, T., Gasser, T., & Stoltze, L. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.05.011 · Cited by 254 · cited 1×
“eases [1] and rheumatoid arthritis [2].”
How should we grade frailty in nursing home patients?
Rockwood, K., Abeysundera, M. J., & Mitnitski, A. (2007) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2007.07.012 · Cited by 249
Immunosuppressive CD14+HLA-DRlow/− monocytes in B-cell non-Hodgkin lymphoma
Lin, Y., Gustafson, M. P., Bulur, P. A., Gastineau, D. A., Witzig, T. E., & Dietz, A. B. (2011) · Blood · doi:10.1182/blood-2010-05-283820 · Cited by 244
S100A9 a new marker for monocytic human myeloid‐derived suppressor cells
Zhao, F., Hoechst, B., Duffy, A., Gamrekelashvili, J., Fioravanti, S., Manns, M. P., Greten, T. F., & Korangy, F. (2012) · Immunology · doi:10.1111/j.1365-2567.2012.03566.x · Cited by 221
Lechner, M. G., Megiel, C., Russell, S. M., Bingham, B., Arger, N., Woo, T., & Epstein, A. L. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-90 · Cited by 209 · cited 3×
“Furthermore, serum IL-6 has been shown to be correlated with MDSC frequency in patients with gastrointestinal cancer [20], and as mentioned above, proinflammatory cytokines are able to induce the differentiation of MDSCs in vitro [5, 8, 21].”
BackgroundMyeloid-derived suppressor cell measurements in fresh and cryopreserved blood samples
Kotsakis, A., Harasymczuk, M., Schilling, B., Georgoulias, V., Argiris, A., & Whiteside, T. L. (2012) · Journal of Immunological Methods · doi:10.1016/j.jim.2012.04.004 · Cited by 199 · cited 3×
“CD15 MDSC subsets are major producers of ROS [7], and hence, the significant increase of this subset in the frail elderly as compared with similarly aged community-dwelling seniors may contribute to the elevated levels of superoxide anion (a major species of ROS) observed in the frail elderly [27].”
BackgroundFricke, I., Mirza, N., Dupont, J., Lockhart, C., Jackson, A., Lee, J.-H., Sosman, J. A., & Gabrilovich, D. I. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0409 · Cited by 182 · cited 8×
“MDSCs (CD33 HLA-DR ) and the CD11b CD15 MDSC subset were found to be increased significantly in seniors (0.29 0.03 and 0.17 0.03, respectively) and the frail elderly (0.40 0.03 and 0.29 0.02, respectively) as compared with healthy adults (0.22 0.03 and 0.11 0.03, respectively; Fig.”
BackgroundInfluentialLeukocyte function in the aging immune system
Desai, A., Grolleau-Julius, A., & Yung, R. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0809542 · Cited by 143 · cited 1×
“[3]), there is a paucity of studies examining rare yet function-”
BackgroundA Role for Immature Myeloid Cells in Immune Senescence
Enioutina, E. Y., Bareyan, D., & Daynes, R. A. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002987 · Cited by 132 · cited 1×
“Enioutina and colleagues [16] recently reported increased levels of tissue”
BackgroundSun, H.-L., Xin Min, Z. H. O. U., Xue, Y., Wang, K., Shen, Y., Mao, J., Guo, H., & Miao, Z. (2012) · PubMed · doi:10.3748/wjg.v18.i25.3303 · Cited by 128 · cited 1×
“been found to be associated with clinical scores, such as tumor stage, burden, and metastasis [10, 15].”
BackgroundDe Martinis, M., Modesti, M., & Ginaldi, L. (2004) · Immunology & Cell Biology · doi:10.1111/j.0818-9641.2004.01242.x · Cited by 128
Impaired innate immunity predicts frailty in old age. The Leiden 85-plus study
van den Biggelaar, A. H. J., Huizinga, T. W. J., de Craen, A. J. M., Gussekloo, J., Heijmans, B. T., Frölich, M., & Westendorp, R. G. J. (2004) · Experimental Gerontology · doi:10.1016/j.exger.2004.06.009 · Cited by 122
Mundy-Bosse, B. L., Young, G. S., Bauer, T., Binkley, E., Bloomston, M., Bill, M. A., Bekaii-Saab, T., Carson, W. E., & Lesinski, G. B. (2011) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-011-1029-z · Cited by 121
Srivastava, M. K., Bosch, J. J., Thompson, J. A., Ksander, B. R., Edelman, M. J., & Ostrand‐Rosenberg, S. (2008) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-008-0490-9 · Cited by 112 · cited 1×
“quency does so in relation to cancers, such as renal and lung carcinoma, of which CD33 HLA-DR CD11b [9–12] and CD33 HLA-DR [13, 14] populations are found to be significantly increased.”
BackgroundCaveolin-1, cellular senescence and age-related diseases
Zou, H., Stoppani, E., Volonte, D., & Galbiati, F. (2011) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2011.11.001 · Cited by 112
Zhou, X., & McElhaney, J. E. (2011) · Vaccine · doi:10.1016/j.vaccine.2010.12.029 · Cited by 106
Tadmor, T., Fell, R., Polliack, A., & Attias, D. (2013) · Hematological Oncology · doi:10.1002/hon.2019 · Cited by 78
Hongli, Sun, Xin, Zhou, Yifeng, Xue, Ke, K., Wang, Yunfeng, Y., ShenI, et al. (2012) · Acta Scientiarum Naturalium Universitatis Sunyatseni · Cited by 70
Korkosz, M., Bukowska-Strakova, K., Sadis, S., Grodzicki, T., & Siedlar, M. (2012) · Blood · doi:10.1182/blood-2012-02-412551 · Cited by 62
Qu, T., Walston, J. D., Yang, H., Fedarko, N. S., Xue, Q.-L., Beamer, B. A., Ferrucci, L., Rose, N. R., & Leng, S. X. (2009) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2008.10.005 · Cited by 61
Baptista, G., Dupuy, A., Jaussent, A., Durant, R., Ventura, E., Sauguet, P., Picot, M., Jeandel, C., & Cristol, J. (2012) · Free Radical Research · doi:10.3109/10715762.2012.692784 · Cited by 56
Volk, A. P. D., Barber, B. M., Goss, K. L., Ruff, J. G., Heise, C. K., Hook, J. S., & Moreland, J. G. (2010) · Journal of Innate Immunity · doi:10.1159/000321439 · Cited by 43
How Age Affects the Biology of Breast Cancer
Thomas, G. A., & Leonard, R. C. (2008) · Clinical Oncology · doi:10.1016/j.clon.2008.11.006 · Cited by 38 · cited 2×
“MDSCs are studied primarily in the context of cancer, and as cancer incidence [18] and mortality rates [17] increase with Figure 1.”
BackgroundResultFung, E., Esposito, L., Todd, J. A., & Wicker, L. S. (2010) · Nature Protocols · doi:10.1038/nprot.2009.246 · Cited by 29
Aging and cancer mortality: Dynamics of change and sex differences
Yang, Y., Li, T., & Nielsen, M. E. (2012) · Experimental Gerontology · doi:10.1016/j.exger.2012.06.009 · Cited by 25 · cited 2×
“MDSCs are studied primarily in the context of cancer, and as cancer incidence [18] and mortality rates [17] increase with Figure 1.”
BackgroundResultTortorella, C., Loria, M. P., Piazzolla, G., Schulze‐Koops, H., Lipsky, P. E., Jirillo, E., & Antonaci, S. (1997) · Archives of Gerontology and Geriatrics · doi:10.1016/s0167-4943(97)00033-2 · Cited by 21
Research works printed but not linked: 1
- 2001, The 65 Years and Older Population: 2000. Census 2000 Brief
Cited by
Understanding the tumor immune microenvironment (TIME) for effective therapy
Binnewies, M., Roberts, E. W., Kersten, K., Chan, V., Fearon, D. F., Merad, M., Coussens, L. M., Gabrilovich, D. I., Ostrand-Rosenberg, S., Hedrick, C. C., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0014-x · Cited by 6,145
Age-dependent dysregulation of innate immunity
Shaw, A. C., Goldstein, D. R., & Montgomery, R. R. (2013) · Nature Reviews Immunology · doi:10.1038/nri3547 · Cited by 1,061
How the ageing microenvironment influences tumour progression
Fane, M., & Weeraratna, A. T. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-019-0222-9 · Cited by 849
Stromal senescence establishes an immunosuppressive microenvironment that drives tumorigenesis
Ruhland, M. K., Loza, A. J., Capietto, A.-H., Luo, X., Knolhoff, B. L., Flanagan, K. C., Belt, B. A., Alspach, E., Leahy, K., Luo, J., et al. (2016) · Nature Communications · doi:10.1038/ncomms11762 · Cited by 496
Myeloid-Derived Suppressor Cells
(2015) · Advances in Cancer Research · doi:10.1016/bs.acr.2015.04.002 · Cited by 482
“Since MDSCs produce IL-6 and IL-1β, these studies also raise the question of whether MDSC production of IL-6 is regulated by IL-1β, and if MDSC production of IL-1β enhances MDSC production of IL-6.”
Background
Metadata
- Authors
- Verschoor, C. P., Johnstone, J., Millar, J., Dorrington, M. G., Habibagahi, M., Lelic, A., Loeb, M., Bramson, J. L., & Bowdish, D. M. E.
- Affiliations
- Michael G. DeGroote Institute for Infectious Disease Research (CA)
- Shiraz University of Medical Sciences (IR)
- Corresponding author
- Bowdish, Dawn M E
- ORCID
- Venue
- Journal of Leukocyte Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-04-01
- Volume
- 93
- Issue
- 4
- Pages
- 633-637
- ISSN
- 0741-5400 (ISSN-L)
- 1938-3673
- PMC
- PMC3701116
- OpenAlex
- W2095746947
- Cited by
- 235
- References
- 39
- Citations by year
- 2026: 10 · 2025: 15 · 2024: 18 · 2023: 12 · 2022: 16 · 2021: 27 · 2020: 21 · 2019: 19 · 2018: 19 · 2017: 19 · 2016: 16 · 2015: 18 · 2014: 16 · 2013: 8
- FWCI
- 10.68
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Journal of Leukocyte Biology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- Canadian Institutes of Health Research
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Keywords
- myeloid-derived suppressor cells, aging, frail elderly, cancer history, immunosenescence, immunosuppression, inflammatory cytokines, TNF-α, interleukin-6, IL-1β
- MeSH terms
- Adult, Aged, Aged, 80 and over, Aging, Cell Differentiation, Female, Fucosyltransferases, HLA-DR Antigens, Humans, Male, Middle Aged, Neoplasms, Tumor Necrosis Factor-alpha, Interleukin-6, Gene Expression, Immunophenotyping, Lewis X Antigen, Myeloid Cells, CD11b Antigen, Interleukin-1beta, Sialic Acid Binding Ig-like Lectin 3
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.